Optimal conditions for lentiviral transduction of engrafting human CD34+ cells. - Wikidata - awgldk - TriplyDB

Optimal conditions for lentiviral transduction of engrafting human CD34+ cells.

Optimal conditions for lentiviral transduction of engrafting human CD34+ cells.

http://www.wikidata.org/entity/Q45869813

about

Hematopoietic stem cell gene therapy:assessing the relevance of preclinical models Integration-specific In Vitro Evaluation of Lentivirally Transduced Rhesus CD34(+) Cells Correlates With In Vivo Vector Copy Number.Decitabine suspends human CD34+ cell differentiation and proliferation during lentiviral transduction.Highly efficient in vitro and in vivo delivery of functional RNAs using new versatile MS2-chimeric retrovirus-like particles.High-efficiency transduction of rhesus hematopoietic repopulating cells by a modified HIV1-based lentiviral vector.Evaluation of engraftment and immunological tolerance after reduced intensity conditioning in a rhesus hematopoietic stem cell gene therapy model Kinetics of lentiviral vector transduction in human CD34(+) cells Transduction of human CD34+ repopulating cells with a self-inactivating lentiviral vector for SCID-X1 produced at clinical scale by a stable cell line.The feasibility of incorporating Vpx into lentiviral gene therapy vectors.TRIM5α variations influence transduction efficiency with lentiviral vectors in both human and rhesus CD34(+) cells in vitro and in vivo.Preclinical demonstration of lentiviral vector-mediated correction of immunological and metabolic abnormalities in models of adenosine deaminase deficiency.Current progress on gene therapy for primary immunodeficiencies.RNA Trans-Splicing Targeting Endogenous β-Globin Pre-Messenger RNA in Human Erythroid Cells.Restriction of HIV-1-based lentiviral vectors in adult primary marrow-derived and peripheral mobilized human CD34+ hematopoietic stem and progenitor cells occurs prior to viral DNA integration.Ex vivo expansion of haematopoietic stem/progenitor cells from human umbilical cord blood on acellular scaffolds prepared from MS-5 stromal cell line.Mice engrafted with human hematopoietic stem cells support a human myeloid cell inflammatory response in vivo.Mathematical modeling of erythrocyte chimerism informs genetic intervention strategies for sickle cell disease.Analysis of ROR1 Protein Expression in Mice with Reconstituted Human Immune System Components.Serum-free Erythroid Differentiation for Efficient Genetic Modification and High-Level Adult Hemoglobin Production.

P2860

Q26859147-86F12EA5-5771-4E50-A234-850FAB8EA8C3 Q33902257-C2104B85-758B-4F6C-9DEE-2DC3DB417128 Q33999887-DBB2452D-0DA5-4C43-B80B-483777DFC99C Q36185032-5AB79C74-28DE-4E47-B3EC-DF0623355000 Q36298679-9DFC5E05-A3F7-4CDC-BF9A-A3CE790FD62D Q36424560-5572DFB0-CBCB-440D-AE0C-11D13D57C661 Q36521989-3FD255D0-DBDE-457E-81BD-260C48156B92 Q37066362-629211F5-8FD8-4667-8F1A-F8A1488CC722 Q37350713-E4E34F87-99EE-42B7-9C96-9D782FC55526 Q37562089-113A6BD7-E71F-4DDB-9635-EC8089AF7302 Q37620826-11CEB884-CC5D-4469-B3E4-5599ED415A9C Q38110363-5D66DB44-8F1D-439E-A5BD-08C0ED9DCD8E Q38749656-B7DF4834-5542-46A9-820F-36931F4567AF Q38797204-0A2ADA36-9C44-42DB-BCF1-7C134339DFD0 Q39363054-75C03C2D-6B80-428F-AF87-B7482A2D5937 Q40529124-F0882DD0-B802-4F9F-9756-501D4CC461D3 Q41660434-07F3BB2A-6584-4BAB-85B5-2F71F675F42B Q54955028-4F082621-B7CE-4FA3-AC21-BE8B33D851C5 Q55004092-EF358228-84D4-4D76-8C30-2C9CB40D43AF

P2860

Optimal conditions for lentiviral transduction of engrafting human CD34+ cells.

http://www.wikidata.org/entity/Q45869813

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

2011年學術文章

@zh-hant

name

Optimal conditions for lentiviral transduction of engrafting human CD34+ cells.

@en

Optimal conditions for lentiviral transduction of engrafting human CD34+ cells.

@nl

type

label

Optimal conditions for lentiviral transduction of engrafting human CD34+ cells.

@en

Optimal conditions for lentiviral transduction of engrafting human CD34+ cells.

@nl

prefLabel

Optimal conditions for lentiviral transduction of engrafting human CD34+ cells.

@en

Optimal conditions for lentiviral transduction of engrafting human CD34+ cells.

@nl

P1433

Q45869813-6B66AD65-5E98-4B67-B8CF-61F90D5065B1

P1476

Q45869813-48D9CEC7-4BA7-4DAB-99C6-717B74057D82

P2093

Q45869813-584F86FD-1CD9-4DEC-93B8-531085E3BF1A

Q45869813-5F78D425-F974-4305-9F5C-43FE68CA50F1

Q45869813-CFECAF7F-F5CE-47FD-A88B-9616E8AD3F6E

Q45869813-D41B9C2D-571B-4BA3-BB87-3C7E63A2F0A1

Q45869813-DC3DC372-1841-4EBD-A4BA-67362D0B6ACF

Q45869813-FDFD62C7-52C5-444C-B101-0C6F6E97FD0B

P2860

Q45869813-11F48E0F-60BF-4A78-AC3A-B9B11F45BF6D

Q45869813-19F60EC0-73CE-489F-AA41-0C449D4ED32A

Q45869813-21384E18-719C-4799-817F-EB46E0452775

Q45869813-2F7D5839-EACB-48CA-97D7-D4A39976CB86

Q45869813-3355994E-6045-4D1C-A8B0-78E30B6AA8C6

Q45869813-3AAADB55-6990-4548-B235-B7E04B5FA21A

Q45869813-3DA98AD4-E937-4F8A-8CEE-935BB00FA3F6

Q45869813-40AFDFCA-DF44-4E5E-984A-D92EB7C9F0CC

Q45869813-4622EB91-0D17-4C31-AD2F-BB9979EF6FCE

Q45869813-4856B794-89E3-47AF-BA9B-E3EB7632A3CE

P2888

Q45869813-8069FBA8-01E0-4E4A-A417-CC76EF577A06

P304

Q45869813-4C14FDB5-0708-4C72-8637-7D5D55061E16

P31

Q45869813-A11F3480-EF94-457D-BA52-0405EE4A6556

P356

Q45869813-1594F6CD-13AC-432C-AF63-5B2EEDBCB204

P433

Q45869813-289F2ED0-2531-466F-AB40-00CA3C99DEC0

P478

Q45869813-B2EF9A94-7BA9-4636-9107-A143D3ED1A5A

P577

Q45869813-49DF0F2B-C7F8-4B2D-8C01-B110BB069192

P5875

Q45869813-F2D5EF41-E697-4B19-9F4C-4957859F6594

P6179

Q45869813-CC03F350-F845-45EF-9B91-87A38157B19B

P698

Q45869813-758F315B-ADD4-4A74-9AC4-8D0F7026EF8A

P932

Q45869813-D977381A-365B-49E8-8D4F-A1C5C00E956E

P356

P1433

P1476

Optimal conditions for lentiviral transduction of engrafting human CD34+ cells.

@en

P2093

C Madison

http://www.w3.org/2001/XMLSchema#string

J F Tisdale

http://www.w3.org/2001/XMLSchema#string

J Hayakawa

http://www.w3.org/2001/XMLSchema#string

K N Washington

http://www.w3.org/2001/XMLSchema#string

M M Hsieh

http://www.w3.org/2001/XMLSchema#string

N Uchida

http://www.w3.org/2001/XMLSchema#string

P2860

Transfusion independence and HMGA2 activation after gene therapy of human β-thalassaemia

Development of functional human blood and immune systems in NOD/SCID/IL2 receptor {gamma} chain(null) mice

Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease

NOD/SCID/gamma(c)(null) mouse: an excellent recipient mouse model for engraftment of human cells

Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy

A nuclear localization signal within HIV-1 matrix protein that governs infection of non-dividing cells

Towards a clinically relevant lentiviral transduction protocol for primary human CD34 hematopoietic stem/progenitor cells.

Correction of sickle cell disease in transgenic mouse models by gene therapy.

Combination of interleukins 3 and 6 preserves stem cell function in culture and enhances retrovirus-mediated gene transfer into hematopoietic stem cells

Permanent and panerythroid correction of murine beta thalassemia by multiple lentiviral integration in hematopoietic stem cells.

P2888

P304

1078-1086

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/GT.2011.63

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

18

http://www.w3.org/2001/XMLSchema#string

P577

2011-05-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51099775

http://www.w3.org/2001/XMLSchema#string

P6179

1033147476

http://www.w3.org/2001/XMLSchema#string

P698

21544097

http://www.w3.org/2001/XMLSchema#string

P932

6525965

http://www.w3.org/2001/XMLSchema#string